GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bionano Genomics Inc (MEX:BNGO) » Definitions » Interest Expense

Bionano Genomics (MEX:BNGO) Interest Expense : MXN-86.5 Mil (TTM As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Bionano Genomics Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Bionano Genomics's interest expense for the three months ended in Sep. 2024 was MXN -1.3 Mil. Its interest expense for the trailing twelve months (TTM) ended in Sep. 2024 was MXN-86.5 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Bionano Genomics's Operating Income for the three months ended in Sep. 2024 was MXN -445.5 Mil. Bionano Genomics's Interest Expense for the three months ended in Sep. 2024 was MXN -1.3 Mil. Bionano Genomics did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Bionano Genomics Interest Expense Historical Data

The historical data trend for Bionano Genomics's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bionano Genomics Interest Expense Chart

Bionano Genomics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Interest Expense
Get a 7-Day Free Trial -43.11 -50.11 -19.02 -5.81 -86.89

Bionano Genomics Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.24 -83.14 -2.03 - -1.34

Bionano Genomics Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN-86.5 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bionano Genomics  (MEX:BNGO) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Bionano Genomics's Interest Expense for the three months ended in Sep. 2024 was MXN-1.3 Mil. Its Operating Income for the three months ended in Sep. 2024 was MXN-445.5 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Sep. 2024 was MXN104.0 Mil.

Bionano Genomics's Interest Coverage for the quarter that ended in Sep. 2024 is calculated as

Bionano Genomics did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Bionano Genomics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bionano Genomics Inc (MEX:BNGO) » Definitions » Interest Expense
Comparable Companies
MHUA YBGJ DXR POCI RVP NSTG PDEX MLSS UEEC OMIC ISRG XPAR:EL BDX XSWX:ALC TSE:7741 WST OCSE:COLO B RMD TSE:4543 XSWX:STMN
Traded in Other Exchanges
BNGO:USA 0A4K:UK
Address
9540 Towne Centre Drive, Suite 100, San Diego, CA, USA, 92121
Website
https://www.bionano.com
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in Americas, EMEA and Asia Pacific; majority revenue being generated from Americas. They generate product revenue from sales of its OGM and Ionic Purification systems and consumables, which includes its instruments, and their VIA software.